[Hemarthrosis as a hemorrhagic complication after thrombolytic treatment].
Hemorrhage of variable severity is the main complication of thrombolytic treatment. We present the case of a rare hemorrhagic location after the use of this treatment for acute myocardial infarction, as ankle hemarthrosis. In the first twelve hours the patient had a joint hemorrhagic effusion with refractory pain and arthrocentesis was required. Recurrence occurred while receiving heparin and after discontinuation of heparin perfusion stopped the patient developed occlusion of the coronary artery related to the infarct requiring emergency angioplasty. We discuss the severity and possible treatment of this situation.
Gallardo
A
A
Servicio de Cardiología. Hospital General de Albacete.
Gallego
J C
JC
Enero
J
J
Barambio
M
M
Domínguez
P
P
Aguilera
M
M
D000328:Adult; D000843:Ankle Joint; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D006395:Hemarthrosis / Q000209:etiology*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D010959:Tissue Plasminogen Activator / Q000009:adverse effects*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator